What's wrong with this picture?

Good news:

And speaking of fantastic news in cancer research, we wanted to call out a more general, and tentative, finding: Today, the New Scientist reports that the drug dichloroacetate (DCA), which is used to treat metabolic disorders, has been found to kill most cancers in early testing. The finding is preliminary and has yet to be tested in human cancer patients, and because DCA is not patented, pharmaceutical companies are unlikely to foot the bill for any such testing. (On the plus side, if DCA does prove to be good for treating cancer, it's likely to be very cheap.)

Bad news (via Digby):

At roughly $2 a dose, there isn't much chance to make a billion on the cancer treatment over the long term.